CellCarta and Tivenix Announce Strategic Partnership to Advance Blood-Based Diagnostics for Alzheimer’s Disease and other Neurodegenerative disorders.
Montreal, Canada & Lugano, Switzerland — July 21, 2025 – CellCarta, a global leader in precision medicine laboratory services, today announced a strategic partnership with Tivenix, a precision diagnostics company focused on neurodegenerative diseases. The two […]